Reardon Andrew (CIK 1950232) reported 71 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-04). Recent activity: Buy LGND (5,000 shares), Sell LGND (105 shares), Sell LGND (33 shares), Sell LGND (157 shares), Sell LGND (1,032 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-04 | LIGAND PHARMACEUTICALS INC (LGND) | CLO & Secretary | Buy | 5,000 | $261,350 |
| 2026-08-04 | LIGAND PHARMACEUTICALS INC (LGND) | CLO & Secretary | Sell | 105 | $29,834 |
| 2026-08-04 | LIGAND PHARMACEUTICALS INC (LGND) | CLO & Secretary | Sell | 33 | $9,390 |
| 2026-08-04 | LIGAND PHARMACEUTICALS INC (LGND) | CLO & Secretary | Sell | 157 | $44,861 |
| 2026-08-04 | LIGAND PHARMACEUTICALS INC (LGND) | CLO & Secretary | Sell | 1,032 | $295,974 |
| 2026-08-04 | LIGAND PHARMACEUTICALS INC (LGND) | CLO & Secretary | Sell | 1,214 | $349,357 |
| 2026-08-04 | LIGAND PHARMACEUTICALS INC (LGND) | CLO & Secretary | Sell | 356 | $102,795 |
| 2026-08-04 | LIGAND PHARMACEUTICALS INC (LGND) | CLO & Secretary | Sell | 503 | $145,771 |
| 2026-08-04 | LIGAND PHARMACEUTICALS INC (LGND) | CLO & Secretary | Sell | 200 | $58,120 |
| 2026-08-04 | LIGAND PHARMACEUTICALS INC (LGND) | CLO & Secretary | Sell | 991 | $289,086 |
| 2026-08-04 | LIGAND PHARMACEUTICALS INC (LGND) | CLO & Secretary | Sell | 409 | $119,763 |
| 2026-07-06 | LIGAND PHARMACEUTICALS INC (LGND) | CLO & Secretary | Buy | 5,000 | $261,350 |
| 2026-07-06 | LIGAND PHARMACEUTICALS INC (LGND) | CLO & Secretary | Buy | 132 | $21,214 |
| 2026-07-06 | LIGAND PHARMACEUTICALS INC (LGND) | CLO & Secretary | Sell | 396 | $122,359 |
| 2026-07-06 | LIGAND PHARMACEUTICALS INC (LGND) | CLO & Secretary | Sell | 104 | $32,261 |
| 2026-07-06 | LIGAND PHARMACEUTICALS INC (LGND) | CLO & Secretary | Sell | 1,119 | $348,815 |
| 2026-07-06 | LIGAND PHARMACEUTICALS INC (LGND) | CLO & Secretary | Sell | 1,081 | $337,573 |
| 2026-07-06 | LIGAND PHARMACEUTICALS INC (LGND) | CLO & Secretary | Sell | 700 | $219,420 |
| 2026-07-06 | LIGAND PHARMACEUTICALS INC (LGND) | CLO & Secretary | Sell | 100 | $31,458 |
| 2026-07-06 | LIGAND PHARMACEUTICALS INC (LGND) | CLO & Secretary | Sell | 900 | $284,200 |
| 2026-07-06 | LIGAND PHARMACEUTICALS INC (LGND) | CLO & Secretary | Sell | 600 | $190,291 |
| 2026-06-02 | LIGAND PHARMACEUTICALS INC (LGND) | CLO & Secretary | Buy | 5,000 | $261,350 |
| 2026-06-02 | LIGAND PHARMACEUTICALS INC (LGND) | CLO & Secretary | Sell | 491 | $109,958 |
| 2026-06-02 | LIGAND PHARMACEUTICALS INC (LGND) | CLO & Secretary | Sell | 677 | $152,459 |
| 2026-06-02 | LIGAND PHARMACEUTICALS INC (LGND) | CLO & Secretary | Sell | 1,432 | $323,585 |
Source: SEC Form 4 filings · as of 2026-08-04